Market Access
Which payer policies deserve the earliest attention?
Know what others can’t by connecting payer policy with the patients, providers and treatment activity affected by it.
Coverage is not the same as access. Connect payer policy, prior authorization, prescribing, patient and cost-of-care signals to see where barriers are emerging and what may be driving them before they limit treatment.
Access barriers rarely affect every patient, payer or market the same way. A policy that appears manageable at the aggregate level can translate into delays, denials or abandonment for specific patient populations.
Understanding where those differences occur, and what is driving them, gives access teams an opportunity to strengthen the evidence, payer strategy and patient support approach before barriers become entrenched.
Which payer policies deserve the earliest attention?
Where does our value story need real-world data in addition to clinical trial evidence?
Which prescriber behaviors and outcomes support the case medical affairs makes to payers?
What is the real cost of standard of care, and which real-world outcomes justify our proposed price to payers?
How exposed is this program to IRA, formulary consolidation, or 340B pressure?
Aggregate coverage and prior authorization reporting can tell you that an access gap exists. It may not reveal which patients experience it, which payer requirements are driving it, how long treatment is delayed or which providers are successfully navigating the same barriers.
Knowing there is friction is different from knowing where, and why, it happens.
Connect payer, patient, prescription, provider and clinical data to understand:
Now the access question isn’t simply “Are we covered?” It’s “What happens to patients after the coverage decision?”*
Bring us your market access question and we’ll help connect payer, patient, provider and treatment signals to reveal where barriers occur and what may be driving them.